We are live on
!
Find out more
6CM
683 Capital Management Portfolio holdings
AUM
$1.92B
1-Year Est. Return
85.52%
This Fund
S&P 500
This Quarter
Est. Return
+15.88%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.52B
AUM Growth
+$72.5M
(+5%)
Cap. Flow
-$111M
Cap. Flow
% of AUM
-7.32%
Top 10 Holdings %
Top 10 Hldgs %
40.87%
Holding
162
New
22
Increased
37
Reduced
54
Closed
28
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
B
Barrick Mining
B
|
+$26.9M |
| 2 |
Sarepta Therapeutics
SRPT
|
+$21.8M |
| 3 |
UWM Holdings
UWMC
|
+$21.1M |
| 4 |
AMTM
Amentum Holdings
AMTM
|
+$12.9M |
| 5 |
Eli Lilly
LLY
|
+$7.96M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$25.8M |
| 2 |
AllianceBernstein
AB
|
+$20.1M |
| 3 |
HES
Hess
HES
|
+$17.1M |
| 4 |
Baidu
BIDU
|
+$16.3M |
| 5 |
TG Therapeutics
TGTX
|
+$11.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.94% |
| 2 | Consumer Discretionary | 9.33% |
| 3 | Financials | 7.76% |
| 4 | Industrials | 6.88% |
| 5 | Materials | 4.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
Palantir
PLTR
$295B
| $93.4M | 6.14% |
685,200
+165,000
| +32% | +$19.4M |
|
2
PUT
Tesla
TSLA
$1.24T
| $91.5M | 6.01% |
288,000
-40,000
| -12% | -$12.1M |
|
|
3
PUT
Eli Lilly
LLY
$1.07T
| $81.9M | 5.38% |
105,000
-10,000
| -9% | -$7.77M |
|
4
Capital One
COF
$124B
| $68.4M | 4.49% |
321,500
+13,500
| +4% | +$2.52M |
|
5
PUT
Strategy Inc
MSTR
$33.5B
| $58.5M | 3.85% |
144,800
-37,300
| -20% | -$13.6M |
|
6
Carvana
CVNA
$43.3B
| $52.2M | 3.43% |
775,000
-85,000
| -10% | -$4.66M |
|
7
PUT
Alnylam Pharmaceuticals
ALNY
$36.3B
| $46.1M | 3.03% |
141,300
+90,100
| +176% | +$24.9M |
|
8
PUT
Madrigal Pharmaceuticals
MDGL
$12.6B
| $46M | 3.02% |
152,000
| – | – |
|
9
GXO Logistics
GXO
$6.06B
| $45.8M | 3.01% |
940,000
-10,000
| -1% | -$398K |
|
|
AMTM
10
Amentum Holdings
AMTM
$5.51B
| $38.5M | 2.53% |
1,630,000
+617,000
| +61% | +$12.9M |
|
11
Hilton Grand Vacations
HGV
$3.84B
| $32.2M | 2.11% |
775,000
+9,000
| +1% | +$340K |
|
|
B
12
Barrick Mining
B
$62.2B
| $28.6M | 1.88% |
+1,375,000
| New | +$26.9M |
|
|
NVO
13
PUT
Novo Nordisk
NVO
$216B
| $27.9M | 1.83% |
404,200
+1,700
| +0.4% | +$116K |
|
14
Wave Life Sciences
WVE
$1.12B
| $26.7M | 1.75% |
4,100,000
+175,000
| +4% | +$1.16M |
|
15
Protagonist Therapeutics
PTGX
$8.75B
| $24.6M | 1.62% |
445,000
-55,000
| -11% | -$2.64M |
|
16
Western Digital
WDC
$179B
| $21.7M | 1.43% |
339,000
-161,000
| -32% | -$7.67M |
|
17
Phathom Pharmaceuticals
PHAT
$912M
| $20.2M | 1.33% |
2,105,000
+660,000
| +46% | +$3.65M |
|
|
18
UWM Holdings
UWMC
$621M
| $19.9M | 1.31% |
+4,800,000
| New | +$21.1M |
|
19
BridgeBio Pharma
BBIO
$16.5B
| $18.4M | 1.21% |
425,000
-150,000
| -26% | -$5.46M |
|
20
uniQure
QURE
$2.68B
| $17.9M | 1.18% |
1,285,000
-265,000
| -17% | -$3.56M |
|
21
PUT
Coinbase
COIN
$41.7B
| $17.9M | 1.17% |
51,000
-50,000
| -50% | -$11.7M |
|
22
Ero Copper
ERO
$2.71B
| $17.7M | 1.17% |
1,050,000
-750,480
| -42% | -$10.1M |
|
23
MeiraGTx Holdings
MGTX
$1.09B
| $17.5M | 1.15% |
2,690,000
+115,000
| +4% | +$679K |
|
24
UnitedHealth
UNH
$382B
| $17.3M | 1.14% |
55,500
+3,500
| +7% | +$1.34M |
|
|
25
PUT
Capital One
COF
$124B
| $16M | 1.05% |
75,000
-50,000
| -40% | -$9.33M |
|
Similar funds
QOP
RIL
MC
RCAG
BOH
DCM
CC
IAN
683 Capital Management's Q2 2025 Portfolio in Review
As of Q2 2025, 683 Capital Management held 162 positions worth $1.52B, up 5% from $1.45B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
683 Capital Management withdrew a net $111M in Q2 2025, closing 28 positions and reducing 54 holdings. Its most notable exit was AllianceBernstein, an estimated $20.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, 683 Capital Management opened a new position in Barrick Mining worth $28.6M.
- 683 Capital Management's largest Q2 2025 buy was Barrick Mining: 1,375,000 shares worth $28.6M.
- 683 Capital Management added most to Sarepta Therapeutics in Q2 2025, an estimated $21.8M increase.
- 683 Capital Management's biggest Q2 2025 reduction was Philip Morris, cutting an estimated $25.8M.
- 683 Capital Management fully exited AllianceBernstein in Q2 2025, selling an estimated $20.1M.
- 683 Capital Management's ten largest holdings make up 41% of its $1.52B portfolio in Q2 2025.
- 683 Capital Management opened 22 new positions and closed 28 in Q2 2025.
- 683 Capital Management's portfolio value rose 5% quarter-over-quarter to $1.52B.
Based on 683 Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.